Feligen CRP, süstesuspensiooni lüofilisaat ja lahusti kassidele
Feligen CRP, süstesuspensiooni lüofilisaat ja lahusti kassidele
Authorised
- Feline calicivirus, strain F9, Live
- Felid herpesvirus 1, strain F2, Live
- Feline panleucopenia virus, strain LR 72, Live
Product identification
Medicine name:
Feligen CRP, süstesuspensiooni lüofilisaat ja lahusti kassidele
Active substance:
- Feline calicivirus, strain F9, Live
- Felid herpesvirus 1, strain F2, Live
- Feline panleucopenia virus, strain LR 72, Live
Target species:
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Feline calicivirus, strain F9, Live1258920.00/cell culture infective dose 501.00dose
-
Felid herpesvirus 1, strain F2, Live3981070.00/cell culture infective dose 501.00dose
-
Feline panleucopenia virus, strain LR 72, Live31623.00/cell culture infective dose 501.00dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI06AD04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Available in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac S.A.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1543
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 8/02/2022
How useful was this page?:
